J. Robbins

发表

Differential Complement Resistance Mediates Virulence of Haemophilus influenzae Type b

A. Sutton, R. Schneerson, S. Kendall-Morris, 1982, Infection and immunity.

The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam.

D. D. Trach, J. Robbins, F. Lin, 2000, The American journal of tropical medicine and hygiene.

Lipid on capsular polysaccharides of gram-negative bacteria.

O. Nishimura, J. Robbins, T. Liu, 1981, The Journal of biological chemistry.

A human monoclonal macroglobulin with specificity for alpha(2----8)- linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1, which crossreacts with polynucleotides and with denatured DNA

K. G. Nickerson, E. Kabat, L. Chess, 1986, The Journal of experimental medicine.

Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children.

R. Schneerson, J. Robbins, B. Claesson, 1990, The Journal of pediatrics.

Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid

S. Szu, A. Fattom, J. Mestecky, 1990, Infection and immunity.

Polysaccharide-protein conjugates: a new generation of vaccines.

R. Schneerson, J. Robbins, 1990, The Journal of infectious diseases.

Antibody-secreting peripheral blood lymphocytes induced by immunization with a conjugate consisting of Streptococcus pneumoniae type 12F polysaccharide and diphtheria toxoid

A. Fattom, J. Mestecky, R. Schneerson, 1990, Infection and immunity.

Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid

J. Shiloach, R. Schneerson, J. Robbins, 1990, Infection and immunity.

Bacterial polysaccharide–protein conjugate vaccines

S. Szu, R. Schneerson, J. Robbins, 1999 .

Effects of infection and disease with Mycobacterium tuberculosis on serum antibody to glucan and arabinomannan: two surface polysaccharides of this pathogen

W. Keitel, R. Schneerson, J. Robbins, 2013, BMC Infectious Diseases.

Identity between polysaccharide antigens of Moraxella nonliquefaciens, group B Neisseria meningitidis, and Escherichia coli K1 (non-O acetylated)

J. Shiloach, S. Devi, R. Schneerson, 1991, Infection and immunity.

Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates

J. C. Parke, J. Schlesselman, J. Shiloach, 1986, Infection and immunity.

Safety and Immunogenicity of Escherichia coli 0157 a-Specific Polysaccharide Conjugate Vaccine in 2-5-Year-Old Children

Y. Shiloach, J. Robbins, Amina Ahmed, 2011 .

Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children.

Y. Shiloach, S. Szu, Jianping Li, 2006, The Journal of infectious diseases.

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

J. Shiloach, D. D. Trach, S. Szu, 2001, The New England journal of medicine.

Comparative Immunogenicity of Group 6 Pneumococcal Type 6A(6) and Type 6B(26) Capsular Polysaccharides

J. Robbins, S. Rastogi, G. Schiffman, 1979, Infection and Immunity.

Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children.

S. Szu, R. Schneerson, J. Robbins, 2003, The New England journal of medicine.

Immunochemical studies of Shigella flexneri 2a and 6, and Shigella dysenteriae type 1 O-specific polysaccharide-core fragments and their protein conjugates as vaccine candidates.

B. Coxon, E. Vinogradov, R. Schneerson, 2010, Carbohydrate research.

Host factors and antibody response Haemophilus influenza type b meningitis and epiglottitis.

J. Schlesselman, J. Robbins, J. Whisnant, 1976, The Journal of infectious diseases.

Specificity and Diversity of Antibodies to Mycobacterium tuberculosis Arabinomannan

A. Casadevall, L. Pirofski, A. Glatman-Freedman, 2003, Clinical Diagnostic Laboratory Immunology.

Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.

J. C. Parke, C. Broome, P. Mäkelä, 1983, The Journal of infectious diseases.

Treatment with Succinic Anhydride Improves the Immunogenicity ofShigella flexneri Type 2a O-Specific Polysaccharide–Protein Conjugates in Mice

J. Shiloach, S. Bystrický, R. Schneerson, 1999, Infection and Immunity.

Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2

Mark A. Miller, R. Schneerson, J. Robbins, 2011, Proceedings of the National Academy of Sciences.

Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1.

S. Devi, R. Schneerson, J. Robbins, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis.

G. Mccracken, J. Robbins, L. Hanson, 1974, The New England journal of medicine.

Glucan Is a Component of the Mycobacterium tuberculosis Surface That Is Expressed In Vitro and In Vivo

A. Casadevall, A. Glatman-Freedman, R. Schneerson, 2002, Infection and Immunity.

Synthesis of a pentasaccharide fragment of Polysaccharide II of Mycobacterium tuberculosis.

J. Robbins, V. Pozsgay, 1995, Carbohydrate research.

Lack of association between group B meningococcal disease and autoimmune disease.

Mark A. Miller, K. Mølbak, N. Nielsen, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.

R. Petralia, D. Lim, Song Gao, 2011, Vaccine.

Effect of the nonreducing end of Shigella dysenteriae type 1 O-specific oligosaccharides on their immunogenicity as conjugates in mice

R. Schneerson, J. Robbins, V. Pozsgay, 2007, Proceedings of the National Academy of Sciences.

The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines.

P. Anderson, D. Smith, R. Schneerson, 1996, JAMA.

Phase 1 Evaluation of Vibrio choleraeO1, Serotype Inaba, Polysaccharide-Cholera Toxin Conjugates in Adult Volunteers

David N. Taylor, S. Szu, J. Robbins, 1998, Infection and Immunity.

Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults

Manfred S. Green, D. Cohen, David N. Taylor, 1997, The Lancet.

Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1.

L. Pannell, R. Schneerson, J. Robbins, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Effect of Dosage on Immunogenicity of a Vi Conjugate Vaccine Injected Twice into 2- to 5-Year-Old Vietnamese Children

J. Shiloach, D. D. Trach, S. Szu, 2004, Infection and Immunity.

Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity

Devi, S. Devi, R. Schneerson, 1991, Infection and immunity.

An Escherichia coli antigen cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b: occurrence among known serotypes, and immunochemical and biologic properties of E. coli antisera toward H. influenzae type b.

J. C. Parke, R. Schneerson, J. Robbins, 1972, Journal of immunology.

A Review: Relation between Invasiveness and the K1 Capsular Polysaccharide of Escherichia coli

G. Mccracken, J. Robbins, M. Glodé, 1976, Pediatric Research.

Investigational vaccine for Escherichia coli O157: phase 1 study of O157 O-specific polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugates in adults.

J. C. Parke, S. Szu, J. Robbins, 1998, The Journal of infectious diseases.

Monocomponent Pertussis Toxoid Vaccine Immunologic and Epidemiologic Experience of Vaccination With a

R. Schneerson, J. Robbins, J. Taranger, 2013 .

Pertussis Vaccine: A Critique

Mark A. Miller, R. Schneerson, J. Robbins, 2009, The Pediatric infectious disease journal.

Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.

R. Schneerson, J. Robbins, J. Taranger, 2001, Pediatrics.

Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.

R. Schneerson, J. Robbins, D. Bryla, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis.

J. Robbins, D. Bryla, J. Taranger, 1997, The Journal of pediatrics.

Phase 1 and Phase 2 Studies of Salmonella enterica Serovar Paratyphi A O-Specific Polysaccharide-Tetanus Toxoid Conjugates in Adults, Teenagers, and 2- to 4-Year-Old Children in Vietnam

D. D. Trach, S. Szu, Jianping Li, 2000, Infection and Immunity.

Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls

J. Shiloach, S. Szu, J. Robbins, 1996, Infection and immunity.

Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine

J. Robbins, D. Watson, S. Szu, 1992, Infection and immunity.

Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.

D. Lim, J. Battey, J. Robbins, 1998, Infection and immunity.

Synthesis and Characterization of Lipooligosaccharide-Based Conjugates as Vaccine Candidates forMoraxella (Branhamella)catarrhalis

J. Chen, D. Lim, J. Battey, 1998, Infection and Immunity.

Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization.

J. Robbins, H. Koornhof, K. Klugman, 1996, Vaccine.

Isolation and characterization of mouse serum alpha 1-antitrypsins.

D. Rodbard, J. Robbins, A. Chrambach, 1972, Analytical biochemistry.

Characterization of the cross-reaction between type 19F(19) and 19A(57) pneumococcal capsular polysaccharides: compositional analysis and immunological relation determined with rabbit typing antisera

D. Carlo, J. Robbins, J. Henrichsen, 1978, Infection and immunity.

Enzymatic measurement of glucose and galactose content pneumococcal capsular polysaccharides.

J. Robbins, C. Lee, 1978, Journal of Biological Standardization.

Immunological studies of Y protein. A major cytoplasmic organic anion-binding protein in rat liver.

J. Robbins, G. Fleischner, I. Arias, 1972, The Journal of clinical investigation.

A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned

R. Schneerson, J. Robbins, J. Taranger, 1996, The Lancet.

Purification of antibodies with immunoadsorbents prepared using bromoacetyl cellulose.

M. Sela, J. Robbins, J. Haimovich, 1967, Immunochemistry.

Synthesis of octa- and dodecamers of D-ribitol-1-phosphate and their protein conjugates.

R. Schneerson, J. Robbins, P. Hoogerhout, 2006, Carbohydrate research.

Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future.

J. Robbins, 1978, Immunochemistry.

Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.

J. Robbins, J. Robbins, 1984, The Journal of infectious diseases.

Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis.

S. Mize, G. Mccracken, J. Robbins, 1974, Lancet.

Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin

R. Gupta, S. Szu, R. Finkelstein, 1992, Infection and immunity.

Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid

J. Shiloach, R. Schneerson, J. Robbins, 1991, Infection and immunity.

Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5.

R. Schneerson, J. Robbins, 1975, The New England journal of medicine.

Association between cross-reacting Escherichia coli K100 and disease caused by Haemophilus influenzae type b

J. C. Parke, G. Mccracken, R. Schneerson, 1978, Infection and immunity.

The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP.

Mark A. Miller, J. Shiloach, R. Schneerson, 2007, Vaccine.

Prevention of Systemic Infections Caused by Group B Streptococcus and Staphylococcus aureus by Multivalent Polysaccharide‐Protein Conjugate Vaccines

A. Fattom, R. Schneerson, J. Robbins, 1995, Annals of the New York Academy of Sciences.

Synthesis andImmunological Properties ofConjugates Composedof GroupB Streptococcus TypeIIICapsular Polysaccharide Covalently BoundtoTetanus Toxoid

J. Robbins, 1990 .

Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate

I. Pastan, J. Shiloach, A. Fattom, 1992, Infection and immunity.

Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A

J. Shiloach, S. Szu, A. Fattom, 1990, Infection and immunity.

Safety and Immunogenicity of Vi Conjugate Vaccines for Typhoid Fever in Adults, Teenagers, and 2- to 4-Year-Old Children in Vietnam

D. D. Trach, S. Szu, R. Schneerson, 1999, Infection and Immunity.

Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A

I. Pastan, J. Shiloach, A. Fattom, 1993, Infection and immunity.

Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals

S. Szu, R. Schneerson, J. Robbins, 1987, The Journal of experimental medicine.

Assessment of Intrapartum Antibiotic Prophylaxis for the Prevention of Early-onset Group B Streptococcal Disease

J. Troendle, P. Azimi, R. Schneerson, 2011, The Pediatric infectious disease journal.

Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies.

A. Bax, J. Shiloach, R. Schneerson, 1985 .

Bacillus pumilus polysaccharide cross-reactive with meningococcal group A polysaccharide

J. Robbins, T. Liu, W. Vann, 1976, Infection and immunity.

Polyribitol-phosphate: an antigen of four gram-positive bacteria cross-reactive with the capsular polysaccharide of haemophilus influenzae type B.

J. Robbins, T. Liu, M. Argaman, 1974, Journal of immunology.

Enteric Bacteria Cross-Reactive with Neisseria meningitidis Groups A and C and Diplococcus pneumoniae Types I and III

R. Schneerson, J. Robbins, R. Myerowitz, 1972 .

Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92.

J. Robbins, T. Liu, M. Glodé, 1977, The Journal of infectious diseases.

The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins.

R. Rappuoli, Yuji Sato, R. Schneerson, 2005, The Journal of infectious diseases.

Pertussis in developed countries

R. Schneerson, J. Robbins, B. Trollfors, 2002, The Lancet.

Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.

R. Schneerson, J. Robbins, D. Bryla, 2000, The Journal of infectious diseases.

Immunity to pertussis. Not all virulence factors are protective antigens.

R. Schneerson, J. Robbins, D. Bryla, 1998, Advances in experimental medicine and biology.

Primum non nocere: a pharmacologically inert pertussis toxoid alone should be the next pertussis vaccine

M. Pittman, R. Schneerson, J. Robbins, 1993, The Pediatric infectious disease journal.

Immunogenicity and safety of a pertussis vaccine composed of pertussis toxin inactivated by hydrogen peroxide, in 18- to 23-month-old children.

R. Schneerson, J. Robbins, I. Krantz, 1990, The Journal of pediatrics.

Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzae.

C. Van Waes, J. Battey, Jianping Li, 2003, Vaccine.

Biological activities of antibodies elicited by lipooligosaccharide based-conjugate vaccines of nontypeable Haemophilus influenzae in an otitis media model.

J. Battey, J. Robbins, J. Sun, 2000, Vaccine.

Autoimmune hemolytic anemia in a child with congenital x-linked hypogammaglobulinemia.

R. G. Skinner, J. Robbins, H. Pearson, 1969, The New England journal of medicine.

Current status and prospects for some improved and new bacterial vaccines.

J. Robbins, F. Robbins, 1986, Annual review of public health.

Haemophilus influenzae Type a Infection and Its Prevention

S. Romero-Steiner, G. Carlone, R. Schneerson, 2007, Infection and Immunity.

Phase 1 Study of a Recombinant Mutant Protective Antigen of Bacillus anthracis

J. Shiloach, S. Leppla, J. Bellanti, 2011, Clinical and Vaccine Immunology.

Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnel.

David N. Taylor, R. Schneerson, J. Robbins, 2008, Vaccine.

Synthesis of a tetrasaccharide building block of the O-specific polysaccharide of Shigella dysenteriae type 1

R. Schneerson, J. Robbins, V. Pozsgay, 1992 .

Relation between structure and immunologic properties of the Vi capsular polysaccharide

S. Szu, J. Robbins, A. Stone, 1991, Infection and immunity.

Standardization and control of meningococcal vaccines, group A and group C polysaccharides.

K. Wong, A. Sutton, J. Robbins, 1977, Journal of biological standardization.

THE ISOLATION AND BIOLOGICAL ACTIVITIES OF RABBIT γM- AND γG-ANTI-SALMONELLA TYPHIMURIUM ANTIBODIES

J. Robbins, K. Kenny, E. Suter, 1965, The Journal of experimental medicine.

polysaccharide-protein conjugate vaccines. Escherichia coli O157 O-specific immunological properties in mice of Preparation, characterization, and

J. Shiloach, S. Szu, J. Robbins, 2013 .

Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines

J. Shiloach, S. Szu, J. Robbins, 1994, Infection and immunity.

Hypothesis: how licensed vaccines confer protective immunity.

S. Szu, R. Schneerson, J. Robbins, 1996, Advances in experimental medicine and biology.

Prospects for the prevention of bacterial meningitis with polysaccharide vaccines.

J. Robbins, E. Gotschlich, R. Austrian, 1978, Bulletin of the World Health Organization.

Structural studies on the sialic acid polysaccharide antigen of Escherichia coli strain Bos-12.

J. Robbins, T. Liu, J. Cohen, 1977, Biochemistry.

Automation of a quantitative immunochemical microanalysis of human serum transferrin: a model system.

J. Robbins, I. Scheinberg, C. J. A. Van Den Hamer, 1970, Clinical chemistry.

Use of Antiserum Agar for Detection of Haemophilus influenzae Type b in the Pharynx

J. Robbins, R. Michaels, Frances E Stonebrake, 1975, Pediatric Research.

Clostridium difficile Recombinant Toxin A Repeating Units as a Carrier Protein for Conjugate Vaccines: Studies of Pneumococcal Type 14, Escherichia coli K1, andShigella flexneri Type 2a Polysaccharides in Mice

R. Schneerson, J. Robbins, D. Bryla, 2000, Infection and Immunity.

Syntheses and Immunologic Properties ofEscherichia coli O157 O-Specific Polysaccharide and Shiga Toxin 1 B Subunit Conjugates in Mice

J. Shiloach, S. Calderwood, S. Szu, 1999, Infection and Immunity.

Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides.

R. Schneerson, J. Robbins, C. Chu, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis.

J. Shiloach, A. Fattom, R. Schneerson, 1996, Journal of the American Society of Nephrology : JASN.

Conjugates of Group A and W135 Capsular Polysaccharides of Neisseria meningitidis Bound to Recombinant Staphylococcus aureus Enterotoxin C1: Preparation, Physicochemical Characterization, and Immunological Properties in Mice

J. Shiloach, B. Coxon, R. Schneerson, 2005, Infection and Immunity.

Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilis influenzae type b capsular polysaccharide‐tetanus toxoid conjugates in two‐to five‐year‐old children with sickle cell anemia

R. Schneerson, J. Robbins, G. Schiffman, 1990, The Pediatric infectious disease journal.

Bacterial meningitis in Egypt: analysis of CSF isolates from hospital patients in Cairo, 1977-78.

J. Robbins, E. Gotschlich, M. El Kholy, 1983, Bulletin of the World Health Organization.

Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide

A. Sutton, R. Schneerson, J. Robbins, 1979, The Journal of experimental medicine.

Quantitative Measurement of “Natural” and Immunization-induced Haemophilus influenzas type b Capsular Polysaccharide Antibodies

J. C. Parke, R. Schneerson, J. Robbins, 1973, Pediatric Research.

Bacterial antigens cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b.

J. C. Parke, R. Schneerson, J. Robbins, 1971, Lancet.

A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine.

R. Schneerson, J. Robbins, E. Gotschlich, 2000, The Pediatric infectious disease journal.

“Love's labours lost”: failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa

R. Schneerson, J. Robbins, E. Gotschlich, 1997, The Lancet.

Meningococcal meningitis reported to WHO in sub-Saharan Africa "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa

J. Robbins, E. Gotschlich, D. Towne, 1997 .

Vaccines for Prevention of Enteric Bacterial Infections Caused by Salmonellae

David N. Taylor, S. Szu, R. Schneerson, 1993 .

Future Vaccine Development at NICHD

R. Schneerson, J. Robbins, 2004, Annals of the New York Academy of Sciences.

Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxin

R. Schneerson, J. Robbins, T. Lagergård, 1992, Infection and immunity.

Production of monovalent antisera by induction of immunological tolerance for capsular typing of Streptococcus pneumoniae

J. Robbins, J. Henrichsen, 1992 .

Prevention of invasive bacterial diseases by immunization with polysaccharide-protein conjugates.

A. Fattom, R. Schneerson, J. Robbins, 1989, Current topics in microbiology and immunology.

Serum antibodies in six-year-old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.

P. Anderson, R. Schneerson, J. Robbins, 1996, The Pediatric infectious disease journal.

Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria.

J. C. Parke, R. Schneerson, J. Robbins, 1975, The Journal of allergy and clinical immunology.

Immunity to Hemophilus influenzae type b. I. The isolation, and some physicochemical, serologic and biologic properties of the capsular polysaccharide of Hemophilus influenzae type b.

R. Schneerson, J. Robbins, L. Rodrigues, 1971, Journal of immunology.

Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumococci

S. Szu, R. Schneerson, J. Robbins, 1986, Infection and immunity.

Further Studies on the Immunogenicity of Haemophilus influenzae Type b and Pneumococcal Type 6A Polysaccharide-Protein Conjugates

R. Schneerson, J. Robbins, S. Rastogi, 1983, Infection and immunity.

Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines.

R. Schneerson, J. Robbins, J. Chippaux, 2003, Bulletin of the World Health Organization.

ANTIBODIES AGAINST HAEMOPHILUS INFLUENZAE TYPE b CAPSULAR POLYSACCHARIDE AND TETANUS TOXOID BEFORE AND AFTER A BOOSTER DOSE OF THE CARRIER PROTEIN NINE YEARS AFTER PRIMARY VACCINATION WITH A PROTEIN CONJUGATE VACCINE

R. Schneerson, J. Robbins, B. Claesson, 2005, The Pediatric infectious disease journal.

J. Shiloach, R. Schneerson, J. Robbins, 2010, Vaccine.

Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice.

E. Vinogradov, R. Schneerson, J. Robbins, 2017, Vaccine.

Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children.

R. Schneerson, J. Robbins, D. Bryla, 1988, The Journal of pediatrics.

Immunity to disease caused by Hemophilus influenzae type b. II. Specificity and some biologic characteristics of "natural," infection-acquired, and immunization-induced antibodies to the capsular polysaccharide of Hemophilus influenzae type b.

J. C. Parke, R. Schneerson, J. Robbins, 1971, Journal of immunology.

Use of antiserum agar plates for serogrouping of meningococci.

J. Robbins, A. Sivonen, O. Renkonen, 1977, Journal of clinical pathology.

Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate.

R. Schneerson, J. Robbins, D. Bryla, 1989, The Journal of pediatrics.

Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi

S. Szu, R. Schneerson, J. Robbins, 1989, Infection and immunity.

Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience.

R. Schneerson, J. Robbins, B. Trollfors, 2013, Vaccine.

Countercurrent immunoelectrophoresis for diagnosis of acute bacterial pneumonia in Chinese children.

R. Schneerson, J. Robbins, X. Shen, 1993, Chinese medical journal.

Toward a new vaccine for pertussis

J. Shiloach, E. Vinogradov, R. Schneerson, 2014, Proceedings of the National Academy of Sciences.

Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies

A. Bax, J. Shiloach, R. Schneerson, 1985, The Journal of experimental medicine.

Bacterial vaccines.

J. Robbins, 1990, Advances in biotechnological processes.

Risk of Adverse Birth Outcome After Group B Meningococcal Disease: Results From A Danish National Cohort

Mark A. Miller, K. Mølbak, R. Schneerson, 2009, The Pediatric infectious disease journal.

10 – Haemophilus influenzae Type b Infections

R. Schneerson, J. Robbins, 1984 .

Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg county, North Carolina (March 1974-March 1976).

J. C. Parke, J. Schlesselman, R. Schneerson, 1977, The Journal of infectious diseases.

Heteroimmunization to the capsular polysaccharide of Haemophilus influenzae type b induced by enteric cross-reacting bacteria

J. C. Parke, R. Schneerson, J. Robbins, 1975, Infection and immunity.

Haemophilus influenzae type b: Disease and Immunity in Humans

R. Schneerson, J. Robbins, M. Argaman, 1973 .

Letter: Staphylococcus aureus antigen in cerebrospinal fluid cross-reactive with Haemophilus influenzae type b antiserum.

G. Keusch, J. Robbins, B. Ribner, 1975, Annals of internal medicine.

volunteers.conjugate vaccines in Israeli Safety and immunogenicity of investigational

Manfred S. Green, J. Shiloach, David N. Taylor, 2013 .

Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers

J. Shiloach, Y. Lerman, D. Cohen, 1996, Infection and immunity.

Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines

J. Shiloach, S. Szu, D. N. Taylor, 1994, Infection and immunity.

Qualitative and quantitative analyses of the antibody response elicited by Haemophilus influenzae type b capsular polysaccharide–tetanus toxoid conjugates in adults with IgG subclass deficiencies and frequent infections

R. Schneerson, J. Robbins, M. Avanzini, 1994, Clinical and experimental immunology.

Comparison between radioimmunoassay and direct and indirect enzyme-linked immunosorbent assays for determination of antibodies against Haemophilus influenzae type b capsular polysaccharide

R. Schneerson, J. Robbins, B. Claesson, 1988, Journal of clinical microbiology.

Clinical, bacteriological, and immunological characterisation of ampicillin-resistant Haemophilus influenzae type B.

J. Maclowry, R. Schneerson, J. Robbins, 1974, Lancet.

Toxoid vaccine for pertussis

R. Schneerson, J. Robbins, J. Taranger, 1997, The Lancet.

Serum Immunoglobulin G Antibody Responses to Bordetella pertussis Lipooligosaccharide and B.parapertussis Lipopolysaccharide in Children with Pertussis and Parapertussis

R. Schneerson, J. Robbins, J. Taranger, 2001, Clinical Diagnostic Laboratory Immunology.

Synthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linker

J. Shiloach, S. Bystrický, S. Szu, 1997, Infection and immunity.

Nonabsorbable Rabbit Anti-Salmonella typhimurium Antibody as Detected by the Complement-Mediated Bactericidal Reaction

J. Robbins, M. Herzberg, K. Kenny, 1966, Journal of bacteriology.

Cross-Immunogenicity of Pneumococcal Group 9 Capsular Polysaccharides in Adult Volunteers

J. C. Parke, S. Szu, J. Robbins, 1982, Infection and immunity.

Immunization of children with pertussis toxoid decreases spread of pertussis within the family.

R. Schneerson, J. Robbins, D. Bryla, 1998, The Pediatric infectious disease journal.

Production of monovalent antisera by induction of immunological tolerance for capsular typing of Streptococcus pneumoniae.

J. Robbins, J. Henrichsen, 1992, FEMS microbiology letters.

Saccharide/protein conjugate vaccines for Bordetella species: preparation of saccharide, development of new conjugation procedures, and physico-chemical and immunological characterization of the conjugates.

E. Vinogradov, R. Schneerson, J. Robbins, 2008, Vaccine.

Haemophilus influenzae type B polysaccharide-protein conjugates: model for a new generation of capsular polysaccharide vaccines.

A. Sutton, R. Schneerson, J. Robbins, 1980, Progress in clinical and biological research.

Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-r EPAsucc conjugate vaccines in one- to four-year-old children

J. Shiloach, R. Schneerson, J. Robbins, 2003, The Pediatric infectious disease journal.

Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.

J. Robbins, H. Cicirello, J. Taranger, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The isolation and biologic activities of purified secretory IgA and IgG anti-Salmonella typhimurium "O" antibodies from rabbit intestinal fluid and colostrum.

J. Robbins, M. Schulkind, D. Eddie, 1971, Journal of immunology.

57 Autoimmune Hemolytic Anemia in a Patient with Congenital Hypogammaglobulinemia

R. G. Skinner, J. Robbins, H. Pearson, 1967, Pediatric Research.

Structural studies of the Escherichia coli K93 and K53 capsular polysaccharides.

A. Bax, M. Summers, R. Schneerson, 1988, Carbohydrate research.

Determination of the structure of the Escherichia coli K100 capsular polysaccharide, cross-reactive with the capsule from type b Haemophilus influenzae.

M. Summers, R. Byrd, R. Schneerson, 1988, Carbohydrate research.

Ultrasonic irradiation of bacterial polysaccharides. Characterization of the depolymerized products and some applications of the process.

G. Zon, S. Szu, R. Schneerson, 1986, Carbohydrate research.

Hydrolytic stability of pneumococcal group 6 (type 6A and 6B) capsular polysaccharides

G. Zon, S. Szu, J. Robbins, 1982, Infection and immunity.

Comparative immunogenicity of vaccines prepared from capsular polysaccharides of group C Neisseria meningitidis O-acetyl-positive and O-acetyl-negative variants and Escherichia coli K92 in adult volunteers.

A. Sutton, J. Robbins, M. Glodé, 1979, The Journal of infectious diseases.

Evaluating the Haemophilus influenzae type b conjugate vaccine PRP-D.

R. Schneerson, J. Robbins, 1990, The New England journal of medicine.

Clinical trials of Shigella vaccines in Israel.

Y. Lerman, D. Cohen, J. Sadoff, 1996, Advances in experimental medicine and biology.

Problems posed by potential gonococcal vaccines viewed from the vantage point of a control agency.

J. Robbins, 1977, The British journal of venereal diseases.

Induction of Serum Vibriocidal Antibodies by O-Specific Polysaccharide-Protein Conjugate Vaccines for Prevention of Cholera

S. Szu, J. Robbins, R. Gupta, 1994 .

An outbreak of Hemophilus influenzae type b meningitis in an enclosed hospital population.

J. Robbins, M. Glodé, W. Khan, 1976, The Journal of pediatrics.

The attack rate, age incidence, racial distribution, and case fatality rate of Hemophilus influenzae type b meningitis in Mecklenbury County, North Carolina.

J. C. Parke, R. Schneerson, J. Robbins, 1972, The Journal of pediatrics.

Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines.

A. Fattom, R. Schneerson, J. Robbins, 2004, American heart journal.

Heterogeneity of the light chains of rabbit immunoglobulin G fractions and of a series of antibodies directed towards antigens of differing complexity.

M. Sela, E. Mozes, J. Robbins, 1967, Immunochemistry.

Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines.

W. Keitel, J. Robbins, J. Zahradnik, 1994, Vaccine.

Light‐scattering spectroscopic study of polysaccharide protein conjugate

W. Bujalowski, B. Chu, A. Patkowski, 1982 .

Molecular size characterization of bacterial capsular polysaccharide vaccines with Sepharose CL-2B.

J. Robbins, J. Mccauley, G. Downing, 1981, Journal of biological standardization.

Sialic acid-containing polysaccharides of Neisseria meningitidis and Escherichia coli strain Bos-12: structure and immunology.

J. Robbins, T. Liu, E. Gotschlich, 1977, The Journal of infectious diseases.

Human cell-surface structures related to Haemophilus influenzae type B disease.

D. Mann, J. Robbins, J. Whisnant, 1971, Lancet.

Polysaccharides of the Genus Bacillus Cross-Reactive with the Capsular Polysaccharides of Diplococcus pneumoniae Type III, Haemophilus influenzae Type b, and Neisseria meningitidis Group A

J. Robbins, R. Gordon, R. Myerowitz, 1973, Infection and immunity.

Vibrio cholerae O139 Conjugate Vaccines: Synthesis and Immunogenicity of V. cholerae O139 Capsular Polysaccharide Conjugates with Recombinant Diphtheria Toxin Mutant in Mice

J. Shiloach, David N. Taylor, S. Szu, 2000, Infection and Immunity.

Development of O-specific polysaccharide-protein conjugates is based upon the protective effect of serum vibriocidal antibodies against cholera

P. Kováč, S. Szu, D. N. Taylor, 1995 .

Human serum 1 -antitrypsin: isolation and demonstration of electrophoretic and immunologic heterogeneity.

J. Robbins, R. Myerowitz, Z. Handzel, 1972, Clinica chimica acta; international journal of clinical chemistry.

Antigenic Evidence of Prevalence and Diversity of Mycobacterium tuberculosis Arabinomannan

A. Casadevall, Anping Li, W. Jacobs, 2004, Journal of Clinical Microbiology.

Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas

D. Lim, J. Battey, J. Robbins, 1997, Infection and immunity.

Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus.

R. Arbeit, J. Robbins, W. Vann, 1984, Diagnostic microbiology and infectious disease.

Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates

J. Shiloach, R. Schneerson, J. Robbins, 2009, Proceedings of the National Academy of Sciences.

Synthesis and physicochemical and immunological characterization of pneumococcus type 12F polysaccharide-diphtheria toxoid conjugates

S. Szu, A. Fattom, A. Sutton, 1988, Infection and immunity.

Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus

R. Arbeit, J. Fournier, R. Schneerson, 1985, Journal of clinical microbiology.

Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.

A. Casadevall, S. Devi, R. Schneerson, 1992, The Journal of infectious diseases.

Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1

E. Moxon, A. Sutton, J. Robbins, 1977, Infection and immunity.

Identification of immunoglobulin heavy-chain isotypes of specific antibodies of horse 46 group B meningococcal antiserum

R. Schneerson, J. Robbins, M. Glodé, 1982, Journal of clinical microbiology.

Identification of a carcinoembryonic antigen binding protein on monocytes.

J. Robbins, A. Ganguly, Ersan Yeltsin, 2003, Biochemical and biophysical research communications.

Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever.

M. Levine, C. Tacket, J. Robbins, 1988, Vaccine.

Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine

D. Maskell, E. Vinogradov, A. Preston, 2011, Proceedings of the National Academy of Sciences.

O-Specific polysaccharide conjugate vaccine-induced IgG antibodies prevent invasion of Shigella into Caco-2 cells and may be curative

I. Barshack, R. Schneerson, J. Robbins, 2007, Proceedings of the National Academy of Sciences.

Towards an Oligosaccharide-Based Glycoconjugate Vaccine Against Shigella dysenteriae Type 1

B. Coxon, R. Schneerson, J. Robbins, 2003 .

Binding of the O-antigen of Shigella dysenteriae type 1 and 26 related synthetic fragments to a monoclonal IgM antibody.

P. Kováč, R. Schneerson, J. Robbins, 1993, The Journal of biological chemistry.

Monospecific serum for typing Haemophilus influenzae type b produced by immunization with Escherichia coli strain 'Easter'.

R. Schneerson, J. Robbins, M. Argaman, 1974, Journal of biological standardization.

THE DEVELOPMENT OF THE IMMUNE RESPONSE

J. Bellanti, J. Robbins, D. Eitzman, 1963, The Journal of experimental medicine.

Cell-free biosynthesis of the O-acetylated N-acetylneuraminic acid capsular polysaccharide of group C meningococci

J. Robbins, T. Liu, W. Vann, 1978, Journal of bacteriology.

Quantitative determination of pneumococcal capsular polysaccharides in the polyvalent vaccine. I. Standardization of an immunoelectrophoretic method.

J. Robbins, C. Lee, S. J. Pearson, 1980, Journal of biological standardization.

Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of the serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPL.

S. Szu, A. Fattom, R. Schneerson, 1991, Journal of immunology.

Protection against pertussis with a monocomponent pertussis toxoid vaccine.

J. Robbins, J. Taranger, B. Trollfors, 1999, Biologicals : journal of the International Association of Biological Standardization.

A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned.

S. Szu, R. Schneerson, J. Robbins, 2013, Vaccine.

Polysaccharide-Based Conjugate Vaccines for Enteric Bacterial Infections: Typhoid Fever, Nontyphoidal Salmonellosis and Escherichia coli O157:H7

S. Szu, R. Schneerson, J. Robbins, 2009 .

Characterization of the Salmonella paratyphi C Vi polysaccharide

R. Schneerson, J. Robbins, W. Egan, 1989, Infection and immunity.

Antibody responses in adult volunteers to pneumococcal polysaccharide types 19F and 19A administered singly and in combination

R. Douglas, J. Robbins, G. Schiffman, 1982, Infection and immunity.

Purification of subunit B of Shiga toxin using a synthetic trisaccharide-based affinity matrix.

J. Shiloach, S. Calderwood, J. Robbins, 1996, Bioconjugate chemistry.

Neonatal meningitis due of Escherichia coli K1.

G. Mccracken, A. Sutton, J. Robbins, 1977, The Journal of infectious diseases.

AN EFFECT OF ANTIGEN-ANTIBODY INTERACTION ON BLOOD COAGULATION

J. Robbins, C. Stetson, 1959, The Journal of experimental medicine.

THE CATABOLISM OF PROTEIN ANTIGENS IN THE NEWBORN AND MATURING RABBIT

J. Robbins, D. Eitzman, Richard T. Smith, 1963, The Journal of experimental medicine.

NORMAL RESPONSE OF SICKLE CELL ANEMIA PATIENTS TO IMMUNIZATION WITH SALMONELLA VACCINES.

J. Robbins, H. Pearson, 1965, The Journal of pediatrics.

A method for producing specific antisera with small doses of immunogen.

E. Nieschlag, J. Robbins, G. Ross, 1971, The Journal of clinical endocrinology and metabolism.

O-specific side-chain toxin-protein conjugates as parenteral vaccines for the prevention of shigellosis and related diseases.

R. Schneerson, J. Robbins, D. Watson, 1991, Reviews of infectious diseases.

FREQUENCY OF E. COLI K ANTIGENS IN URINARY-TRACT INFECTIONS IN CHILDREN

J. Robbins, B. Kaijser, U. Jodal, 1977, The Lancet.

Pneumocystis carinii pneumonia and primary immune deficiency diseases of infancy and childhood.

J. Robbins, P. Walzer, M. Schultz, 1973, The Journal of pediatrics.

SUCCESSFUL TREATMENT OF PNEUMOCYSTIS CARINII PNEUMONITIS IN A PATIENT WITH CONGENITAL HYPOGAMMAGLOBULINEMIA.

J. Robbins, R. Miller, H. Pearson, 1965, The New England journal of medicine.

Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes

R. Gupta, S. Szu, J. Robbins, 1995, Infection and immunity.

An unusual occurrence of sporotrichosis. Eight cases in one residence.

J. Robbins, H. Garrett, 1960, Archives of dermatology.

Pneumocystis Carinii Pneumonitis A Review

J. Robbins, John B. Robbins, 1967, Pediatric Research.

An increasing awareness of pneumocystis carinii pneumonitis.

V. Devita, J. Robbins, 1972, The Annals of thoracic surgery.

Development and evaluation of an enzyme-linked immunosorbent assay for serum Vi antibodies for detection of chronic Salmonella typhi carriers

M. Levine, G. Losonsky, J. Robbins, 1987, Journal of clinical microbiology.

Vietnam Teenagers , and 2-to 4-Year-Old Children in Vaccines for Typhoid Fever in Adults , Safety and Immunogenicity of Vi Conjugate

D. D. Trach, S. Szu, R. Schneerson, 1999 .

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates

A. Sutton, R. Schneerson, J. Robbins, 1980, The Journal of experimental medicine.

An unusual occurrence of sporotrichosis.

J. Robbins, H. Garrett, 1960 .

Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum.

S. Szu, R. Schneerson, J. Robbins, 1995, The Journal of infectious diseases.

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

S. Black, A. Fattom, R. Schneerson, 2002, The New England journal of medicine.

Studies on Limulus lysate coagulating system.

T. Sakmar, S. Liang, J. Robbins, 1979, Progress in clinical and biological research.

Chemical approaches to bacterial vaccines. synthesis of mycobacterial oligosaccharide-protein conjugates for use as serodiagnostics and immunogens

J. Robbins, V. Pozsgay, E. Dubois, 1996 .

On the Antigenic Determinants of the Lipopolysaccharides of Vibrio cholerae O:1, Serotypes Ogawa and Inaba*

P. Kováč, S. Bystrický, S. Szu, 1998, The Journal of Biological Chemistry.

Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme disease.

B. Coxon, R. Schneerson, J. Robbins, 2011, Carbohydrate research.

Soluble antigen-antibody complexes as intermediates in the purification of antibodies in 8 molar urea.

M. Sela, J. Robbins, L. I. Slobin, 1966, Archives of biochemistry and biophysics.

A synthetic octasaccharide mimics the native, O-specific determinant of the Shigella dysenteriae type 1 lipopolysaccharide

R. Schneerson, J. Robbins, C. Glaudemans, 1992 .

Synthetic oligosaccharides as tools to demonstrate cross-reactivity between polysaccharide antigens.

B. Coxon, R. Schneerson, J. Robbins, 2012, The Journal of organic chemistry.

Synthesis of a tetrasaccharide donor corresponding to the O-specific polysaccharide of Shigella dysenteriae type 1.

R. Schneerson, J. Robbins, V. Pozsgay, 1993, Carbohydrate research.

Synthesis and some immunologic properties of an O-acetyl pectin [poly(1-->4)-alpha-D-GalpA]-protein conjugate as a vaccine for typhoid fever

S. Bystrický, S. Szu, J. Robbins, 1994, Infection and immunity.

A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival.

E. Unanue, A. Casadevall, Bing Chen, 1998, Proceedings of the National Academy of Sciences of the United States of America.

QUANTITATIVE STUDIES OF THE IMMUNOGLOBULIN SEQUENCE IN THE RESPONSE OF THE RABBIT TO A SOMATIC ANTIGEN

W. Altemeier, J. Robbins, R. Smith, 1966, The Journal of experimental medicine.

Poly(γ-d-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: A potential addition to the anthrax vaccine

J. Shiloach, S. Leppla, A. Yergey, 2003, Proceedings of the National Academy of Sciences of the United States of America.

IMMUNE REACTIONS AND BLOOD

J. Robbins, C. Stetson, 2003 .

Restaurant-associated outbreak of typhoid fever in Maryland: identification of carrier facilitated by measurement of serum Vi antibodies

J. Robbins, F. Lin, C. Groves, 1988, Journal of clinical microbiology.

Safety and Immunogenicity of ImprovedShigella O-Specific Polysaccharide-Protein Conjugate Vaccines in Adults in Israel

J. Shiloach, R. Schneerson, J. Robbins, 2001, Infection and Immunity.

Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology?

Mark A. Miller, R. Schneerson, J. Robbins, 2006, Vaccine.

γA-Immunoglobulin from Rabbit Colostrum

J. Robbins, J. Cebra, 1966, The Journal of Immunology.

Urinary-tract escherichia coli with cross-reactive antigens to encapsulated pyogenic bacteria.

R. Schneerson, J. Robbins, M. Turck, 1972, Lancet.

The specific secondary biological activities of rabbit IgM and IgG anti-Salmonella typhimurium 'O' antibodies isolated during the development of the immune response.

J. Robbins, M. Herzberg, M. Schulkind, 1972, Immunology.

Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25

J. Shiloach, R. Schneerson, J. Robbins, 2007, Proceedings of the National Academy of Sciences.

The development of the immune response. Studies on the agglutinin response to Salmonella flagellar antigens in the newborn rabbit.

J. Bellanti, J. Robbins, D. Eitzman, 1963 .

Horse Anti-Pneumococcal Immunoglobulins. II. Specific Mouse Protective Activity

J. Robbins, W. C. Hill, 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Serogroup identification of Neisseria meningitidis: comparison of an antiserum agar method with bacterial slide agglutination

C. Frasch, D. Craven, J. Robbins, 1978, Journal of Clinical Microbiology.

Identification of Salmonella typhi in faecal specimens by an antiserum-agar method.

J. Robbins, C. Nolan, E. Laborde, 1980, Journal of medical microbiology.

Gamma-A-immunoglobulin from rabbit colostrum.

J. Robbins, J. Cebra, 1966, Journal of immunology.

The infant rat as a model of bacterial meningitis.

E. Moxon, A. Sutton, J. Robbins, 1977, The Journal of infectious diseases.

A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates

V. Nussenzweig, R. Schneerson, J. Robbins, 2009, Proceedings of the National Academy of Sciences.

Protective roles of mucosal and serum immunity against typhoid fever.

R. Schneerson, J. Robbins, Y. Yang, 1988, Monographs in allergy.

Surveillance for bacterial meningitis by means of polymerase chain reaction.

R. Schneerson, J. Robbins, E. Gotschlich, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chimeric Vaccines Against Japanese Encephalitis, Dengue, and West Nile

F. Guirakhoo, T. Monath, R. Rappuoli, 2004 .

Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types

S. Clarke, S. Szu, J. Robbins, 1983, Infection and immunity.

Development of an improved vaccine for anthrax.

J. Shiloach, S. Leppla, R. Schneerson, 2002, The Journal of clinical investigation.

Cellular localization of ligandin in rat, hamster and man.

J. Robbins, G. Fleischner, I. Arias, 1977, Biochemical and biophysical research communications.

Characterization of precipitating antibodies to ruminant serum and milk proteins in humans with selective IgA deficiency.

A. Lyerly, J. Robbins, R. Buckley, 1971, The New England journal of medicine.

Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.

M. Levine, C. Tacket, J. Robbins, 1986, The Journal of infectious diseases.

Characterization of a human monoclonal immunoglobulin M (IgM) antibody (IgMBEN) specific for Vi capsular polysaccharide of Salmonella typhi

K. G. Nickerson, E. Kabat, S. Bystrický, 1995, Infection and immunity.

Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.

R. Schneerson, J. Robbins, R. Dagan, 1999, The Journal of infectious diseases.

Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age.

R. Schneerson, J. Robbins, D. Bryla, 1991, The Pediatric infectious disease journal.

The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines

S. Szu, R. Schneerson, J. Robbins, 2011, Clinical and Vaccine Immunology.

Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates

J. Shiloach, B. Curfman, J. Vickers, 1984, Infection and immunity.

Purification of heat-labile enterotoxin from Escherichia coli O78:H11 by affinity chromatography with antserum to Vibrio cholerae toxin.

J. Robbins, Z. Dafni, 1976, The Journal of infectious diseases.

Chlamydia pneumoniae Viability i n A therosclerotic Tissue: True o r F alse?

R. Schneerson, J. Robbins, B. Trollfors, 2000 .

A placebo-controlled trial of a pertussis-toxoid vaccine.

W. Blackwelder, J. Robbins, J. Taranger, 1995, The New England journal of medicine.

Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus.

J. Shiloach, R. Schneerson, J. Robbins, 2009, Vaccine.

Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component

S. Leppla, E. Vinogradov, R. Schneerson, 2008, Proceedings of the National Academy of Sciences.

Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants.

J. Robbins, D. Bryla, J. Taranger, 1997, The Pediatric infectious disease journal.

The control of polyvalent pneumococcal polysaccharide vaccines

J. Robbins, 1979 .

Preparation and Characterization of Group A Meningococcal Capsular Polysaccharide Conjugates and Evaluation of Their Immunogenicity in Mice

R. Schneerson, J. Robbins, C. Chu, 2003, Infection and Immunity.

Induction of Haemophilus influenzae Type b Capsular Antibody in Neonatal Rabbits by Gastrointestinal Colonization with Cross-Reacting Escherichia coli

R. Schneerson, J. Robbins, R. Myerowitz, 1973, Infection and immunity.

R. Schneerson, J. Robbins, 1971, Infection and immunity.

MINIREVIEW Haemophilus influenzae Type a Infection and Its Prevention

S. Romero-Steiner, G. Carlone, R. Schneerson, 2007 .

Measurement of Haemophilus Influenzae Type A Capsular Polysaccharide Antibodies in Cord Blood Sera

K. Bieging, S. Romero-Steiner, D. S. Schmidt, 2012, The Pediatric infectious disease journal.

Specific Secondary Biological Properties of Purified Rabbit Immunoglobulin M and Immunoglobulin G Antibodies to Brucella abortus and Bordetella pertussis

J. Robbins, M. Herzberg, M. Schulkind, 1971, Infection and immunity.

Expression of a Mycobacterium tuberculosis Arabinomannan Antigen In Vitro and In Vivo

A. Casadevall, A. Glatman-Freedman, R. Schneerson, 2001, Infection and Immunity.

Reversal of aconitine-induced tachycardia by prostaglandins in the rabbit Langendorff preparation.

J. Robbins, R. Tanz, B. Harwood, 1977, Cardiovascular Research.

Synthesis of Gamma-globulin in the New-born Rabbit

J. Bellanti, J. Robbins, D. Eitzman, 1963, Nature.

THE EFFECT OF X-RAY IRRADIATION UPON THE SEQUENCE OF IMMUNE GLOBULINS FOLLOWING INITIAL IMMUNIZATION IN THE RABBIT.

J. Robbins, R. Smith, 1964, Journal of immunology.

STUDIES ON MECHANISMS CONTROLLING THE IMMUNOGLOBULIN COMPONENTS OF THE IMMUNE RESPONSE.

J. Robbins, R. Smith, 1967 .

Haemophilus influenzae type b: the search for a vaccine.

R. Schneerson, J. Robbins, 1987, The Pediatric infectious disease journal.

Polysaccharide–Protein Conjugate Vaccines

R. Schneerson, J. Robbins, V. Pozsgay, 2011 .

Correlation between Net Charge of Antigens and Electrophoretic Mobility of Immunoglobulin M Antibodies

M. Sela, E. Mozes, J. Robbins, 1967, Nature.

Comparative Long-term Adverse Effects Elicited by Invasive Group B and C Meningococcal Infections

R. Schneerson, J. Robbins, M. Nardini, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunity to Pertussis

R. Schneerson, J. Robbins, D. Bryla, 1998 .

Evasion of host defenses: group report.

A. Tomasz, J. Skehel, D. Wiley, 1980 .

Additional Conjugation Methods and Immunogenicity of Bacillus anthracis Poly-γ-d-Glutamic Acid-Protein Conjugates

R. Schneerson, J. Robbins, J. Kubler-Kielb, 2006, Infection and Immunity.

Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005.

R. Rappuoli, M. Caulfield, B. Plikaytis, 2006, Vaccine.

Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.

R. Thapa, R. Schneerson, J. Robbins, 1987, The New England journal of medicine.

Reactivities of shark 19S and 7S IgM antibodies to Salmonella typhimurium.

J. Robbins, L. Clem, M. Schulkind, 1971, Nature: New biology.

Immunochemical evidence for the development of an "acquired" hypogammaglobulinemic state.

J. Robbins, E. Ellis, D. Eitzman, 1966, The New England journal of medicine.

Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins

D. Lim, J. Robbins, C. Tsai, 1996, Infection and immunity.

Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types

S. Clarke, S. Szu, J. Robbins, 1983, Infection and immunity.

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates

A. Sutton, R. Schneerson, J. Robbins, 1980, The Journal of experimental medicine.

The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines

S. Szu, R. Schneerson, J. Robbins, 2011, Clinical and Vaccine Immunology.

International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19–20 July 2007☆

E. Hewlett, K. Edwards, G. Carlone, 2008, Vaccine.

Prevention of Haemophilus influenzae type b disease in humans.

D. Smith, J. Robbins, 1974, Preventive medicine.

Serum anticapsular polysaccharide antibodies confer immunity to invasive diseases caused by Haemophdus influenzae type b (HIB) t (1-10). These anti-type b antibodies exert their protective effect by initiating complement-mediated activities including opsonization and bacterial lysis (2-5, 11). A pro

R. Schneerson, J. Robbins, O. Barrera, 1980 .

Results of vaccination in patients with IgA deficiency and/or IgG subclass deficiencies.

R. Schneerson, J. Robbins, M. Avanzini, 1986, Annali Sclavo. Collana monografica.